Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding study

BACKGROUND: Erlotinib and pemetrexed have been approved for the second-line treatment of non-small cell lung cancer (NSCLC). These two agents have different mechanisms of action. Combined treatment with erlotinib and pemetrexed could potentially augment the antitumor activity of either agent alone....

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Minami, Seigo, Kijima, Takashi, Takahashi, Ryo, Kida, Hiroshi, Nakatani, Takeshi, Hamaguchi, Masanari, Takeuchi, Yoshiko, Nagatomo, Izumi, Yamamoto, Suguru, Tachibana, Isao, Komuta, Kiyoshi, Kawase, Ichiro
格式: Artigo
語言:Inglês
出版: BioMed Central 2012
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3437193/
https://ncbi.nlm.nih.gov/pubmed/22809298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-296
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍